EMA Authorised: Adrovance (colecalciferol;alendronic acid (as sodium trihydrate)) — Organon N.V.

View source ↗

Summary

The European Medicines Agency authorised Adrovance, a fixed-dose combination of colecalciferol (vitamin D3) and alendronic acid (as sodium trihydrate), for oste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis
• Postmenopausal Osteoporosis

Drugs mentioned

• Adrovance (colecalciferol; alendronic acid (as sodium trihydrate))

Snippet

Status: Authorised. Therapeutic area: Osteoporosis, Postmenopausal. MAH: Organon N.V.. Decision date: 12/02/2026